SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Alexion Pharmaceuticals, Inc. (ALXN)
An SI Board Since October 1997
Posts SubjectMarks Bans Symbol
824 29 0 ALXN
Emcee:  Larry Liebman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
774OT Re: BCRX Sounds to me like they'll drop that indication, possibly blow otuck-3/27/2007
773My assumption.keokalani'nui-3/27/2007
772??? That shouldn't be too hard to fix? <i>The company said recent statom pope-3/27/2007
771Redeploying alxn into bcrx.keokalani'nui-3/27/2007
770Wilder, good question on why not $1M, where do you draw a line? <<We conrkrw-3/27/2007
769Alexion shares gain on Soliris pricing Shares of Alexion Pharmaceuticals Inc. jIcebrg-3/27/2007
768< I am assuming once drug company gets involved, insurance is no longer good keokalani'nui-3/26/2007
767>>How does this work in practice - it negates the whole co-pay and could eIRWIN JAMES FRANKEL-3/26/2007
766alxn said they're committed to all patients getting the drug. If i were an irkrw-3/26/2007
765<i> True. But assume you do not object to this profiteer eating the copayRobohogs-3/26/2007
7642 thoughts - First, the cap on many medical plans is $1-2 MM USD (mine is 2) -Robohogs-3/26/2007
763Plus, I don't do post-commercialization well. Not that I ever really see itkeokalani'nui-3/26/2007
762Hi Wilder, I appreciate the reaction to the pricing. I think we can be sure itIRWIN JAMES FRANKEL-3/26/2007
761"Insane pricing"... It is really bugging me. I have to think the workeokalani'nui-3/26/2007
760Time to do it is now. Let the acquirer think they can expand the market.keokalani'nui-3/26/2007
759Pricing is insane. Fully diluted market cap around $2B but pricing soliris to rkrw-3/26/2007
758Checklist 1. Price drug. 2. Sell company. Please.keokalani'nui-3/26/2007
757Drug priced at $387k. I was guessing $325k.kenhott-3/26/2007
756At least PDLI are good at collecting money:-)eomdr.praveen-3/21/2007
755From 8-K: On March 15, 2007, Oklahoma Medical Research Foundation, or OMRF, filkeokalani'nui-3/21/2007
754Biotech firm sues Alexion Steve Higgins, Register Business Editor 03/20/2007 CHIcebrg-3/21/2007
753Ian, Maybe we can agree to disagree :-)rkrw-3/20/2007
752Also, Solaris wasn't a "huge" risk in PNH. 'No-risk' is mokeokalani'nui-3/20/2007
751Jim, Regardless of a $100k or $300K annual price, they'll be perceived as gIan@SI-3/20/2007
750Ian you're kind of missing the point a bit. alxn would be plenty rewarded ifrkrw-3/20/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News